Cepham’s Luteye Centers on Cellular Senescence to Protect Aging Eyes
01 mai 2024 08h30 HE
|
Cepham
Cepham announces the launch of Luteye to combat the effects of aging on eyes.
Bitcoin Well Provides Preliminary Year End Update and Bitcoin Super Company Vision
21 févr. 2024 08h35 HE
|
Bitcoin Well
Preliminary, unaudited Q4 growth numbers for Bitcoin Well and Bitcoin Super Company vision outline.
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
06 févr. 2024 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
01 févr. 2024 01h03 HE
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
23 janv. 2024 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Morgan Gustafson Promoted to Jr. Art Director at Hummingbird Creative Group
16 janv. 2024 15h37 HE
|
Hummingbird Creative Group
Cary, North Carolina, USA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Hummingbird Creative Group, a brand strategy and creative agency in Cary, North Carolina, announced the promotion of Morgan Gustafson to...
[Latest] Global Pulp and Paper Automation Market Size/Share Worth USD 12.4 Billion by 2032 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
02 oct. 2023 17h30 HE
|
Custom Market Insights
Austin, TX, USA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pulp and Paper Automation Market Size, Trends and Insights By Product...
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
18 sept. 2023 05h59 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
Neuromeka Participates in FABTECH 2023, Unveiling 3D Vision Collaborative Robot Welding Solution
13 sept. 2023 18h45 HE
|
Neuromeka USA, Inc.
CHICAGO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Neuromeka unveiled its collaborative robot welding solution during FABTECH 2023, North America's largest metal forming, fabricating, welding and finishing...
ONL Therapeutics Completes Enrollment in Phase 2 Study of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachment
28 août 2023 07h00 HE
|
ONL Therapeutics
More than 135 patients recruited in four months for Phase 2 study of a single intravitreal (IVT) injection of ONL1204 Ophthalmic Solution as adjunct to standard-of-care surgery Topline data readout...